An overview of Buruli ulcer in Australia.


Journal

Australian journal of general practice
ISSN: 2208-7958
Titre abrégé: Aust J Gen Pract
Pays: Australia
ID NLM: 101718099

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 3 9 2024
Statut: ppublish

Résumé

Buruli ulcer (BU) is caused by Mycobacterium ulcerans, an environmental pathogen that causes severe skin and soft-tissue necrosis. In Australia, cases of BU are acquired in endemic regions, which include Victoria and Far North Queensland, but those who have visited these regions can present to health practitioners anywhere. This article provides Australian general practitioners with an overview of BU, including its epidemiology, transmission, clinical features, diagnosis and management. BU can manifest as an ulcer or as a non-ulcerated skin lesion, such as a plaque, nodule or oedema. Diagnosis can be achieved with a dedicated Mycobacterium ulcerans polymerase chain reaction (PCR) test performed on a wound swab. Swabs on non-ulcerated disease have a high false negative rate, and a PCR test should be performed on a tissue biopsy to confirm disease. Most cases are managed with prolonged antibiotic therapy - commonly a combination of oral rifampicin and clarithromycin or fluroquinolone (moxifloxacin or ciprofloxacin) - and wound dressings.

Sections du résumé

BACKGROUND BACKGROUND
Buruli ulcer (BU) is caused by Mycobacterium ulcerans, an environmental pathogen that causes severe skin and soft-tissue necrosis. In Australia, cases of BU are acquired in endemic regions, which include Victoria and Far North Queensland, but those who have visited these regions can present to health practitioners anywhere.
OBJECTIVE OBJECTIVE
This article provides Australian general practitioners with an overview of BU, including its epidemiology, transmission, clinical features, diagnosis and management.
DISCUSSION CONCLUSIONS
BU can manifest as an ulcer or as a non-ulcerated skin lesion, such as a plaque, nodule or oedema. Diagnosis can be achieved with a dedicated Mycobacterium ulcerans polymerase chain reaction (PCR) test performed on a wound swab. Swabs on non-ulcerated disease have a high false negative rate, and a PCR test should be performed on a tissue biopsy to confirm disease. Most cases are managed with prolonged antibiotic therapy - commonly a combination of oral rifampicin and clarithromycin or fluroquinolone (moxifloxacin or ciprofloxacin) - and wound dressings.

Identifiants

pubmed: 39226606
doi: 10.31128/AJGP-08-23-6914
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

671-674

Auteurs

Daniel P O'Brien (D)

MBBS, FRACP, DMedSc, DipAnat, Deputy Director, Department of Infectious Diseases, Barwon Health, Geelong, Vic; Department of Medicine and Infectious Diseases, Royal Melbourne Hospital, Melbourne, Vic.

Christopher Chun Wen Wong (CCW)

MD, BParaSci, GradCertClinEd, Infectious Disease Registrar, Victorian Infectious Disease Service, The Royal Melbourne Hospital, Melbourne, Vic.

Stephen Muhi (S)

BSc, BMedSc, MBBS, MPHTM, MClinEd, FACTM, FFTM, FRACP, Infectious Diseases Physician, Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Melbourne, Vic; Department of Microbiology and Immunology, University of Melbourne, Melbourne, Vic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH